Page 8 - Laboratory manual for students FAR222 2019 20
P. 8

FAR 222 Dosage Form II                                                    Laboratory Manual


               adjustment is necessary if the patient is intolerant of pain and discomfort. Viscosity agent may
               help to reduce some of the pain and discomfort if it is simply not possible to prepare the
               solution within an acceptable range of tonicity. A hypotonic ophthalmic solution will require the
               addition of a substance (tonicity adjusting agent) to attain the proper tonicity range.


               ii.  Buffers

               The adjustment of pH in eye drops is important as eyes are sensitive to pH changes. Majority
               of ophthalmic drugs are weak bases and buffering is needed to maintain the stability of the
               drugs in the formulation. In most cases, the addition of buffer could help in adjusting the tonicity
               of ophthalmic products.

               Commonly used buffers are shown in Table 2.


               Table 2 Commonly used Buffers for Ophthalmic Products

                                   Borate       Tris-HCl buffer                                Citrate
                    Types                                             Phosphate buffer
                                   buffer                                                      buffer
                      pH          6.8 – 9.1        7.2 – 9.0              4.5 – 8.5           2.5 – 6.5
                                                      Tris
                                                                      Sodium chloride,
                                 Boric acid,    (hydroxymethyl)      potassium chloride,     Citric acid,
                                   sodium       aminomethane                                   sodium
                Composition  borate/borax       and hydrochloric      sodium hydrogen        citrate and
                                                                         phosphate,
                                 and sodium           acid             monopotassium           sodium
                                  chloride                                                     chloride
                                                                         phosphate


               iii. Preservatives
               Aqueous eye drops, unless in single-dose form are prepared in a vehicle which is bactericidal
               and fungicidal; for this purpose, phenylmercuric nitrate or acetate (0.002 %w/v) benzalkonium
               chloride (0.01 %w/v) and chlorhexidine acetate (0.01 %w/v) are generally suitable, the choice
               being governed in certain circumstances by the compatibility of the antimicrobial substance
               with the other ingredients and by the period of time that the eye drops are likely to be used.
               Benzalkonium  chloride  is  not  suitable  as  a  preservative  for  eye  drops  containing  local
               anaesthetics.
               Eye drops are formulated for use by instilling one or two drops into the conjunctival sac, and
               they  are  not  suitable  for  introduction  into  the  anterior  chamber  of  the  eye  during  surgical
               procedures. Solutions for the latter purpose should likewise be sterile but should not contain
               any preservative.
               Commonly used preservatives are shown in Table 3.








                                                                                                        6
   3   4   5   6   7   8   9   10   11   12   13